The case for considering it is straightforward: the underlying drug class (GLP-1 receptor agonists) has the strongest weight management evidence base in clinical pharmacology, supported by multiple large-scale randomized controlled trials showing 15-22% weight reduction in study populations over 68-72 weeks
Knowing the basics of half-life can help you make sense of what your body is experiencing
I think patient choice is paramount
In this reel, we explain: What was recalled Why it happened Whether patients should be worried Why doctors are asking for greater transparency What you should do if you're taking semaglutide Do not stop your medication without speaking to your treating doctor
Proper storage isnt just about freshness, its about safety
For once-weekly injections, administer the missed dose as soon as possible if within the specified timeframe (e.g., within 5 days for semaglutide, at least 3 days before the next dose for dulaglutide)